The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The epidemiology of non‐alcoholic fatty liver disease
Open accessAbstract
The increase in Non‐alcoholic Fatty Liver Disease (NAFLD) and the imminent disappearance of chronic viral hepatitis thanks to new and effective therapies is motivating hepatologists to change their clinical approach to chronic liver disease.NAFLD‐cirrhosis or NAFLD‐Hepatocellular Carcinoma (HCC) are now the second cause of liver transplantation in the USA. This short‐review is focused to the epidemiology of NAFLD/Non‐alchoholic Steatohepatitis (NASH), including the definition of this disease which should be revised as well discussing the prevalence, risk factors for progression, natural history and mortality.NAFLD is considered to be the hepatic manifestation of the metabolic syndrome (MS). It affects 25‐30% of the general population and the risk factors are almost identical to those of MS. The natural history involves either the development of cardiovascular diseases or cirrhosis and HCC.HCC can also develop in NASH in the absence of cirrhosis (45% of cases). We conclude that an international consensus conference on the definition, natural history, policies of surveillance and new pharmacological treatments of NAFLD and NASH is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Self-citationCryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Adams, L. A., Sanderson, S., Lindor, K. D., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.012 · Cited by 911
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Wong, V. W.-S., Wong, G. L.-H., Choi, P. C.-L., Chan, A. W.-H., Li, M. K.-P., Chan, H.-Y., Chim, A. M.-L., Yu, J., Sung, J. J.-Y., & Chan, H. L.-Y. (2010) · Gut · doi:10.1136/gut.2009.205088 · Cited by 648
Piscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604
Self-citationTargher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
Poonawala, A., Nair, S. P., & Thuluvath, P. J. (2000) · Hepatology · doi:10.1053/jhep.2000.17894 · Cited by 569
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 552
Sheth, S. G., Gordon, F. D., & Chopra, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00008 · Cited by 513
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 501
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Williamson, R. M., Price, J. F., Glancy, S., Perry, E., Nee, L. D., Hayes, P. C., Frier, B. M., Van Look, L. A. F., Johnston, G. I., Reynolds, R. M., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2229 · Cited by 391
Gastaldelli, A., Kozakova, M., Hφjlund, K., Flyvbjerg, A., Favuzzi, A., Mitrakou, A., & Balkau, B. (2009) · Hepatology · doi:10.1002/hep.22845 · Cited by 377
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
Cortez-Pinto, H., Camilo, M. E., Baptista, A., De Oliveira, A. G., & De Moura, M. C. (1999) · Clinical Nutrition · doi:10.1016/s0261-5614(99)80015-6 · Cited by 301
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Caballería, L., Pera, G., Auladell, M. A., Torán, P., Muñoz, L., Miranda, D., Alumà, A., Casas, J. D., Sánchez, C., Gil, D., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832fcdf0 · Cited by 239
Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis
Browning, J. D., Kumar, K. S., Saboorian, M. H., & Thiele, D. L. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04059.x · Cited by 227
Incidence and natural course of fatty liver in the general population: The Dionysos study
Bedogni, G., Miglioli, L., Masutti, F., Castiglione, A., Crocè, L. S., Tiribelli, C., & Bellentani, S. (2007) · Hepatology · doi:10.1002/hep.21827 · Cited by 226
Self-citationImpact of coffee on liver diseases: a systematic review
Saab, S., Mallam, D., Cox, G. A., & Tong, M. J. (2014) · Liver International · doi:10.1111/liv.12304 · Cited by 220
Ekstedt, M., Franzén, L. E., Holmqvist, M., Bendtsen, P., Mathiesen, U. L., Bodemar, G., Ekstedt, M., Franzén, L. E., Holmqvist, M., Bendtsen, P., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802555991 · Cited by 208
Noureddin, M., Yates, K. P., Vaughn, I. A., Neuschwander-Tetri, B. A., Sanyal, A. J., McCullough, A., Merriman, R., Hameed, B., Doo, E., Kleiner, D. E., et al. (2013) · Hepatology · doi:10.1002/hep.26465 · Cited by 196
Predictors of non-alcoholic fatty liver disease in obese children
Sartorio, A., Del Col, A., Agosti, F., Mazzilli, G., Bellentani, S., Tiribelli, C., & Bedogni, G. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602588 · Cited by 183
Self-citationModerate alcohol use and health: A consensus document
Poli, A., Marangoni, F., Avogaro, A., Barba, G., Bellentani, S., Bucci, M., Cambieri, R., Catapano, A. L., Costanzo, S., Cricelli, C. A., et al. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.02.007 · Cited by 178
Self-citationRECURRENCE OF NONALCOHOLIC STEATOHEPATITIS FOLLOWING LIVER TRANSPLANTATION1
Kim, W. R., Poterucha, J. J., Porayko, M. K., Dickson, E. R., Steers, J. L., & Wiesner, R. H. (1996) · Transplantation · doi:10.1097/00007890-199612270-00021 · Cited by 168
Loomba, R. S., Bettencourt, R., & Barrett-Connor, E. L. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04141.x · Cited by 115
Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients
Hamaguchi, E., Takamura, T., Sakurai, M., Mizukoshi, E., Zen, Y., Takeshita, Y., Kurita, S., Arai, K., Yamashita, T., Sasaki, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0148 · Cited by 112
Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation
Molloy, R. M., KOMOROWSKI, R. A., & Varma, R. R. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030212 · Cited by 99
Liver Fibrosis Progression in Hepatitis C Virus Infection After Seroconversion
Butt, A. A., Yan, P., Re, V. L., Rimland, D., Goetz, M. B., Leaf, D. A., Freiberg, M. S., Klein, M. B., Justice, A. C., & Sherman, K. E. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6502 · Cited by 85
Caserta, C. A., Pendino, G. M., Amante, A., Vacalebre, C., Fiorillo, M. T., Surace, P., Messineo, A., Surace, M., Alicante, S., Cotichini, R., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq073 · Cited by 85
Steatosis and steatohepatitis in postmortem material from Northwestern Greece
Zois, C. D., Baltayiannis, G.-H., Bekiari, A., Goussia, A., Karayiannis, P., Doukas, M., Demopoulos, D., Mitsellou, A., Vougiouklakis, T., Mitsi, V., et al. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i31.3944 · Cited by 72
Imhof, A., Kratzer, W., Boehm, B. O., Meitinger, K., Trischler, G., Steinbach, G., Piechotowski, I., & Köenig, W. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9181-7 · Cited by 68
Radu, C., Grigorescu, M. D., Crișan, D., Lupșor‐Platon, M., Constantin, D., & Dina, L. A. (2008) · PubMed · Cited by 68
Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient
Carson, K., Washington, M. K., Treem, W. R., Clavien, P., & Hunt, C. M. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030211 · Cited by 62
Nonalcoholic Steatohepatitis: Reply
Sheth, S. G., Gordon, F. D., & Chopra, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-5-199709010-00019 · Cited by 57
Cited by
Cobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
NAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449
MAFLD: How is it different from NAFLD?
Gofton, C., Upendran, Y., Zheng, M.-H., & George, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0367 · Cited by 423
Molecular Pathogenesis of Cholangiocarcinoma
Labib, P. L., Goodchild, G., & Pereira, S. P. (2019) · BMC Cancer · doi:10.1186/s12885-019-5391-0 · Cited by 310
Metadata
- Authors
- Bellentani, S.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2017-01
- Volume
- 37
- Issue
- S1
- Pages
- 81-84
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2578670173
- Cited by
- 606
- References
- 43
- FWCI
- 57.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.